Stay updated with breaking news from Willish Navarro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aadi initiates Phase 2 trial investigating the combination of nab-sirolimus with letrozole for the treatment of advanced or recurrent endometrioid-type endometrial cancer LOS ANGELES, Oct. 19,...
Two new real-world next-generation sequencing studies reinforce prevalence of TSC1/2 mutations in up to 2% of all tumors, a significant addressable cancer population PRECISION1 tumor-agnostic trial...
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
LOS ANGELES, Sept. 20, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. , a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway...